In conclusion, our results generally do not support the hypothesis that circulating levels of IGF-1 and IGFBP-3, or the molar IGF-I/IGFBP-3 ratio are associated with the risk of pancreatic cancer, which confirms the results of most previous prospective studies. Here, IGFBP3 is linked to familial pancreatic carcinoma.